Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 9.03
+0.05 (0.56%)
Jun 18, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 6.43 billion as of June 18, 2026. Its market cap has increased by 21.65% in one year.
Market Cap
6.43B
Enterprise Value
4.44B
Revenue
681.17M
Ranking
n/a
PE Ratio
91.24
Stock Price
9.03
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 6.43B, a decrease of -26.14%. That is a compound annual growth rate of -6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 6.43B | -26.45% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LongBio Pharma (Suzhou) | 10.39B |
| HBM Holdings | 9.74B |
| Everest Medicines | 9.31B |
| CARsgen Therapeutics Holdings | 9.25B |
| Suzhou Ribo Life Science | 8.53B |
| CStone Pharmaceuticals | 7.29B |
| Shanghai Haohai Biological Technology | 7.22B |
| Alphamab Oncology | 6.92B |